Professor of Cardiovascular Medicine, Honorary Consultant Cardiologist. Specialist adult cardiovascular care: putting research into practice to benefit patients
The Safe Hearts Plan, unveiled by the European Commission on 16 December 2025, is the first ever EU approach to tackling cardiovascular disease, Europe’s number 1 killer, & a part of the European Health Union. share.google/wmsb26pQEn6uGJG…
Did you know cardiovascular risk factors develop silently?
That's why countries across Europe are taking action during EU Screening Week.
Ireland will support screening activities during World Heart Week and engage national policymakers.
Latvia will host a national awareness and screening event offering expert advice.
Malta will bring screening and prevention information directly into local communities.
👉 Check what's planned where you live, and take part: ow.ly/zaWY50ZQqlP#EUScreeningWeek#HeartHealth#WorldHeartDay#SafeHeartsPlan@OliverVarhelyi@EU_Health
As the UK marks 100 days until the Smokefree Generation law, new data from
@AshOrgUK shows that 6 in 10 young people who have ever smoked regret it. Smoking remains a leading preventable cause of heart attacks and strokes, causing tens of thousands of deaths each year in the UK.
In this article we propose that pulmonary disorders should be incorporated into a cardio–kidney–metabolic–pulmonary (#CKMP) framework. academic.oup.com/eurjhf/arti…
Atrial fibrillation density (the clustering/dispersion over time of #AFib episodes) shows a dose–response association with ischaemic #stroke, independent of AF burden
academic.oup.com/eurheartj/a…
❤️ Your heart won't wait. Neither should you.
During EU Screening Week:
Finland will launch their nationwide awareness and screening campaign.
Greece will offer community-based blood pressure and blood glucose checks through pharmacies.
Hungary will host a Community Cardiovascular Health Day with free screening and expert advice.
Small checks today can prevent major health problems tomorrow.
👉 Discover activities in your country and join the movement to know your numbers: ow.ly/vLNm50ZPIPR#KnowYourNumbers#EUScreeningWeek#Prevention#SafeHeartsPlan@OliverVarhelyi@EU_Health
CardioNugget™ 🫀 | Anthracycline cardiotoxicity ≠ always irreversible
The old dogma: anthracycline cardiomyopathy is permanent.
The reality: early dysfunction can be meaningfully reversible.
💡 Timing is everything.
In the Cardinale cohort, 82% improved with HF therapy (11% complete + 71% partial recovery), with recovery strongly linked to earlier treatment.
Think of it as a window of opportunity:
Early detection → GDMT → myocardial recovery
Delayed detection → LV remodeling/dilation → ↓ chance of recovery
📌 Take-home: Don’t label anthracycline cardiotoxicity as uniformly irreversible. Catch it early and treat it early.
#CardioNugget#CardioOncology#Anthracyclines#HeartFailure#Cardiology
Our short take on the cardiovascular disease modern service framework for England: a 10-year plan to reduce heart disease & stroke academic.oup.com/eurheartj/a…
What is the optimal blood pressure target in AMI-related cardiogenic shock?
The randomised NORshock trial will compare a permissive hypotension strategy (MAP 55 mmHg) with standard noradrenaline-mediated MAP targets (≥65 mmHg), assessing whether reduced vasopressor use can improve clinical outcomes.
eurointervention.pcronline.c…@Margriet_Bogerd@shock_doc2015@CHassager@KSjauw@joyland2704@ICUDocAP